| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/29/2022 | 47.06% | Canaccord Genuity | $5.5 → $7 | Maintains | Buy |
| 08/18/2022 | 47.06% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 08/04/2022 | 26.05% | HC Wainwright & Co. | $5 → $6 | Maintains | Buy |
| 03/25/2022 | -41.18% | Canaccord Genuity | → $2.8 | Initiates Coverage On | → Buy |
| 06/27/2019 | — | Craig-Hallum | Downgrades | Buy → Hold |
HIVE Blockchain Techs Questions & Answers
The latest price target for HIVE Blockchain Techs (NASDAQ: HIVE) was reported by Canaccord Genuity on August 29, 2022. The analyst firm set a price target for $7.00 expecting HIVE to rise to within 12 months (a possible 47.06% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for HIVE Blockchain Techs (NASDAQ: HIVE) was provided by Canaccord Genuity, and HIVE Blockchain Techs maintained their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HIVE Blockchain Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HIVE Blockchain Techs was filed on August 29, 2022 so you should expect the next rating to be made available sometime around August 29, 2023.
While ratings are subjective and will change, the latest HIVE Blockchain Techs (HIVE) rating was a maintained with a price target of $5.50 to $7.00. The current price HIVE Blockchain Techs (HIVE) is trading at is $4.76, which is out of the analyst's predicted range.